Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. - Wikidata - awgldk - TriplyDB

Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.

Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.

http://www.wikidata.org/entity/Q33351611

about

Suicidal behavior and depression in smoking cessation treatments Efficacy of pharmacotherapies for short-term smoking abstinance: a systematic review and meta-analysis.Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century Efficacy of psychostimulant drugs for amphetamine abuse or dependence Pharmacological interventions for smoking cessation: an overview and network meta-analysis Efficacy of Psychostimulant Drugs for Amphetamine Abuse or Dependence Best practices for smoking cessation interventions in primary care Effects of tobacco smoke exposure in childhood on atopic diseases Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized-controlled trials comparison with venlafaxine Common and distinct neural targets of treatment: changing brain function in substance addiction Varenicline and Risk of Self-Harm: A Nested Case-Control Study Identifying Subgroups among Hardcore Smokers: a Latent Profile Approach Epistaxis and other haemorrhagic events associated with the smoking cessation medicine varenicline: a case series from two national pharmacovigilance centres.The effect of smoking on arterial stiffness.Implementing tobacco dependence treatment during clinical consultations: a qualitative study of clinicians' experiences, perceptions and behaviours in a South African primary health care setting.A pragmatic, randomized, controlled study evaluating the impact of access to smoking cessation pharmacotherapy coverage on the proportion of successful quitters in a Canadian population of smokers motivated to quit (ACCESSATION).Evaluation of inconsistency in networks of interventions National guidelines for smoking cessation in primary care: a literature review and evidence analysis.Estimating ethnic differences in self-reported new use of antidepressant medications: results from the Multi-Ethnic Study of Atherosclerosis.Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey.[Predictive factors for smoking initiation and quitting among a cohort of Chilean women followed for 5.5 years].Treatment models for targeting tobacco use during treatment for cannabis use disorder: case series.Identification of a new selective dopamine D4 receptor ligand.Smoking and increased Alzheimer's disease risk: a review of potential mechanisms How confident should we be that smoking cessation treatments work?The effect of smoking cessation counselling in pregnant women: a meta-analysis of randomised controlled trials.Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals.Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era.Varenicline for tobacco dependence: panacea or plight?Efficacy of a dose range of surinabant, a cannabinoid receptor blocker, for smoking cessation: a randomized controlled clinical trial.Motivational Interviewing for encouraging quit attempts among unmotivated smokers: study protocol of a randomized, controlled, efficacy trial.Effectiveness of pharmacologic therapies on smoking cessation success: three years results of a smoking cessation clinic.Effective behaviour change techniques in smoking cessation interventions for people with chronic obstructive pulmonary disease: a meta-analysis.Neuroscience of behavioral and pharmacological treatments for addictions Targeting nicotine addiction: the possibility of a therapeutic vaccine.Correlates of former smoking in patients with cerebrovascular disease: a cross-sectional study.Differentiating the primary reinforcing and reinforcement-enhancing effects of varenicline Varenicline for smoking cessation: is it a heartbreaker?Modeling naturalistic craving, withdrawal, and affect during early nicotine abstinence: A pilot ecological momentary assessment study.Self-reported exposure to policy and environmental influences on smoking cessation and relapse: a 2-year longitudinal population-based study.

P2860

Q21089921-BFD028CF-9687-4927-BFB4-475A635BCEAD Q21093272-D041685B-D826-44E6-9334-CEB66BDCBB58 Q22305613-BEEE090F-16CA-40C2-9569-8BBEAFEE49D5 Q24198261-899E3422-17D9-4ECF-A0FB-C5F5D73BA6B4 Q24202961-2223CA4B-448B-4564-B690-468037E99B08 Q24203609-6690EFB6-A723-4A5C-A065-367E9C633D96 Q24645515-CDE8252D-DDF1-4CDA-B676-EFB0A126C84E Q26824235-614B22D8-5D76-4426-863D-7A61F00E1B03 Q26864531-94305338-3601-4098-B1EC-0D80574D6E6A Q27027961-D3CB2A65-3171-432F-AE8C-49024B0A7177 Q28554332-5167CC2D-FC9E-4B3D-A4CA-9810AA926E58 Q28646516-1AF2E50C-8FF7-4C76-8689-7243093BA3D0 Q33399574-8B02BDBB-9624-4315-A899-3B8C240DEE1E Q33551158-288A2072-6FB5-45AD-87CA-72F8D00AA815 Q33597412-F4BF515F-412C-4E36-88F3-EF3BCD859BF0 Q33618099-93551F50-E89E-49F4-8CD2-535A53320B06 Q33620679-D7C4E8CC-50E6-49BA-BBE5-D07A7880CD07 Q33697741-BD215E3D-7D56-49B7-9647-ACBF93048E4C Q33748358-FA9F0CE2-6B83-4373-9E1A-E5AA561E2D11 Q33767740-85E21B39-040D-4A2B-A9E2-622F8000466C Q33786433-CBEEFF59-EA41-4FD6-B5EF-BECFBA5082DB Q33791704-F5291692-111F-4990-8E10-67E59B5A7526 Q33896124-97C35A93-1777-45E3-A444-91829D96A546 Q33902721-2C7A3AD2-3473-48D8-97CE-6DDACC24406E Q33925108-BC961D1A-695A-437C-9A4C-0AE6E882FE04 Q34006401-DC95A80F-05B5-4D5B-8DA5-E0C174B85840 Q34049603-D1FB623C-2EA9-4CFF-BCD1-65C6BA311136 Q34172133-6CED50EC-1518-44CA-842A-978C3AF3E116 Q34190097-0ED1984E-8648-4169-9452-4EDE760C21CA Q34244610-7AA62B61-CF2D-442B-AA45-12DE28A6E330 Q34309077-F8BF95CF-883A-4B0A-87EF-17C341475DCD Q34402246-EA685F70-0C6F-422F-A529-61319CC4B64B Q34618687-0FED15B5-258E-4EFE-9E97-2600134C1C3C Q34714494-59904ADC-7138-4D43-8C99-C7A32A7E65AF Q34987300-88D69C24-7027-427A-B756-BF493CF215A6 Q35008147-3E304089-F488-4186-81E2-A2080F59809B Q35079394-0D92D057-F3A0-4DC0-BAEC-C6466941F3C2 Q35201184-459B62F0-1930-460A-A3D8-14615E970C8B Q35298102-0330BF21-318C-4188-BD76-64280D9D252D Q35357208-AAA6F861-EFA4-4EA3-8AD4-C89FE82F0ABE

P2860

Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.

http://www.wikidata.org/entity/Q33351611

description

2008 nî lūn-bûn

@nan

2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.

@ast

Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.

@en

type

label

Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.

@ast

Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.

@en

prefLabel

Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.

@ast

Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.

@en

P1433

Q33351611-3B9A2A1A-8F00-4861-88DF-4845DA2A2181

P1476

Q33351611-3DCCB836-C826-4507-914F-545B64EB908A

P2093

Q33351611-6AA39C25-A67E-40BD-B452-8D678A4B4E69

Q33351611-75B54C69-9B5B-4E2C-BA2A-88A5351A6073

Q33351611-9E078C05-B973-4549-B71A-96C8C336C6CB

Q33351611-A04E3433-31EE-4959-B17F-A290FF3A34F4

Q33351611-A2533DC5-FB13-473F-946F-41F49D594EF1

Q33351611-AD419F6D-3734-4662-AF83-B371C5B05049

Q33351611-ADE36976-70CA-4F5C-AD9B-56F50767F095

Q33351611-AFEA9E95-02B1-4E40-9686-EA7289CC3C9B

Q33351611-E1DFA6E6-5E92-4A28-A888-223B8B2671AC

P2860

Q33351611-006E4AEE-9B70-4E7B-9567-A607A61C58C0

Q33351611-03128BB7-54B8-4E96-A617-98F7225D2066

Q33351611-059E9396-7898-4DC2-AD6A-AE50AF5AE169

Q33351611-06DC2859-A916-4D94-B3EE-E7C66941CB2E

Q33351611-09D009A3-89FC-4E03-BFC2-136A8CD8DBE2

Q33351611-0D5B1C3D-C5FC-4974-8EBA-3B45F75A6555

Q33351611-11CE5B37-3436-4027-845B-5E771AB89FED

Q33351611-21BBDA29-0C0D-4EFE-95F8-17789E0B5C15

Q33351611-2A1D1EEA-5CF5-4BF8-95A5-897115A7CB80

Q33351611-2C4D6B4B-7B5B-4088-86AF-BC76FEAD2BE3

P304

Q33351611-E6635C43-7E2D-46DD-81F2-5433347D00DA

P31

Q33351611-1134043E-BE08-4072-ACAE-299205B4C055

Q33351611-7d741a54-85cb-4b13-8b16-cdcd346e3732

P356

Q33351611-68B3BA77-736C-4155-BC55-07825AEBE805

P407

Q33351611-5C9CC53B-15BA-45C6-88F2-964FD0F10259

P433

Q33351611-80E70556-CC8C-4C78-BE4B-46E90EFBBF99

P478

Q33351611-9CB58427-5E92-45E3-8D22-F6DC8BF6343E

P50

Q33351611-A4634ACF-FEAB-447A-BD16-5091B43B9422

Q33351611-A7E045AD-D122-4B4A-8445-F4CFE2209ED1

P577

Q33351611-7D7C7979-193E-4053-86A7-04ACE955C1CC

P5875

Q33351611-50C44837-232C-4E66-ACC9-25DC605FB05E

P698

Q33351611-3FF847C4-B436-4773-8532-F049B016C6AE

P921

Q33351611-432583A9-85FE-4940-9F42-A00D0433473B

P932

Q33351611-25403930-01B4-4586-B20F-53355B76A33C

P356

P1433

Canadian Medical Association Journal

P1476

Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.

@en

P2093

André Gervais

http://www.w3.org/2001/XMLSchema#string

Daniel Yavin

http://www.w3.org/2001/XMLSchema#string

Gilles Paradis

http://www.w3.org/2001/XMLSchema#string

Jennifer O'Loughlin

http://www.w3.org/2001/XMLSchema#string

Lawrence Joseph

http://www.w3.org/2001/XMLSchema#string

Mark J Eisenberg

http://www.w3.org/2001/XMLSchema#string

Patrick Bélisle

http://www.w3.org/2001/XMLSchema#string

Salvatore Mottillo

http://www.w3.org/2001/XMLSchema#string

Stephane Rinfret

http://www.w3.org/2001/XMLSchema#string

P2860

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation

Nicotine replacement therapy for smoking cessation

Antidepressants for smoking cessation

A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation.

Placebo controlled trial of nicotine chewing gum in general practice.

Randomised controlled trial of nicotine chewing-gum

Efficacy of bupropion in the indigenous Maori population in New Zealand.

Rimonabant--a selective CB1 antagonist.

P304

135-144

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1503/CMAJ.070256

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

179

http://www.w3.org/2001/XMLSchema#string

P50

Kristian B Filion

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5226360

http://www.w3.org/2001/XMLSchema#string

P698

18625984

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy

P932

2443223

http://www.w3.org/2001/XMLSchema#string